Evidence map›Paper›PMID 41929816›Full record

ArticleProceedings of SPIE--the International Society for Optical Engineering2026

Implementation of a Prospective, Multi-Center Clinical Study of Dynamic Contrast Fluorescence Imaging to Diagnose Necrotizing Soft-Tissue Infection - Challenges and Lessons Learned.

Eric R Henderson, Morgan T Mazanec, Chelsey L Recendez, Jon M Anderson, Cameron Woods, Logan M Bateman, Zachary Soucy, Scott W Rodi, Ida Leah Gitajn, Jaimo Ahn and 17 more

Abstract read
In one paragraph

Article in Proceedings of SPIE--the International Society for Optical Engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Eric R HendersonDartmouth Health, Lebanon, NH.
Morgan T MazanecDartmouth Health, Lebanon, NH.
Chelsey L RecendezDartmouth Health, Lebanon, NH.
Jon M AndersonDartmouth Health, Lebanon, NH.
Cameron WoodsDartmouth Health, Lebanon, NH.
Logan M BatemanGeisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH.
Zachary SoucyDartmouth Health, Lebanon, NH.
Scott W RodiDartmouth Health, Lebanon, NH.
Ida Leah GitajnDartmouth Health, Lebanon, NH.
Jaimo AhnEmory School of Medicine, Atlanta, GA.
Sunil SinghalPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Niels D MartinPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Jane KeatingPerelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Nicholas M BernthalDavid Geffen School of Medicine at UCLA, Los Angeles, CA.
Christopher LeeDavid Geffen School of Medicine at UCLA, Los Angeles, CA.
Eben RosenthalVanderbilt University Medical Center, Nashville, TN.
William T ObremskeyVanderbilt University Medical Center, Nashville, TN.
Jonathan G SchoeneckerVanderbilt University Medical Center, Nashville, TN.
Joseph ForresterStanford Medicine at Stanford University, Palo Alto, CA.
Kurt WeissUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
Graciela BauzaUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
Lauren RosenblumUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
Rebecca E KotcherUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
Mary Molly HunterUniversity of Michigan Medical School, Ann Arbor, MI.
Raymond JeanUniversity of Michigan Medical School, Ann Arbor, MI.
Samuel S StreeterGeisel School of Medicine at Dartmouth, Dartmouth College, Hanover, NH.
Jonathan T ElliottDartmouth Health, Lebanon, NH.

Funding

Real-Time Diagnosis of Life-Threatening Necrotizing Soft-Tissue Infections Using Indocyanine Green Kinetic ModelingR01AI184513 · NIAID · DARTMOUTH-HITCHCOCK CLINIC · PI Jonathan T Elliott, Saeed Hassanpour · 2025 to 2026
$1.4M
NIAID NIH HHS R01 AI184513
6 · The paper itself

Abstract

Necrotizing soft-tissue infections (NSTIs) are rapidly progressive and highly lethal, with diagnostic uncertainty contributing to treatment delays and mortality rates approaching 30%. To address this challenge, a multi-center clinical trial has been initiated to evaluate dynamic contrast-enhanced fluorescence imaging (DCE-FI) with indocyanine green as a rapid diagnostic tool. This technology enables visualization of microvascular thrombi characteristic of NSTIs, distinguishing them from less severe infections. The trial engages seven tertiary centers within a collaborative NSTI study group. This presentation will focus on the execution and implementation of this complex, multi-institutional study, including processes for protocol harmonization, regulatory coordination, and standardized imaging workflows. A key element of implementation was the development of real-time, smartphone-accessible didactic materials to ensure consistent imaging technique, data acquisition, and troubleshooting across all participating sites. Emphasis will be placed on the strategies used to maintain study fidelity and ensure successful completion across centers, enabling validation of DCE-FI as a transformative diagnostic adjunct in NSTI care.

Indexed as

contrastdynamicFluorescence-guided surgeryimplementationindocyanine greeninfectionnecrotizing

Identifiers

PMID41929816
PMCPMC13042105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.